News from BAT Research & Development
A series of cell-based tests developed to compare the biological impact of cigarette smoke with e-cigarette vapour revealed no activity in cells exposed to vapour from Vype ePen, a commercially available e-cigarette. In contrast, when the cell culture systems were exposed to cigarette smoke, they exhibited a series of responses including stress responses, DNA damage and cellular transformation, depending on the assay used.
BAT’s Pre-Clinical Assessment Manager, Dr Marinna Gaça, presented on Acute inhalation toxicity: in vitro and ex vivo systems in a webinar covering State-of-the-science, practical application, and dosimetry considerations for in vitro and ex vivo methods.
A novel hybrid product that combines e-cigarette technology with fresh tobacco, called ‘ glo iFUSE’, has been shown to successfully deliver natural tobacco flavours without impacting the potentially reduced risk nature of the aerosol produced.
BAT’s Chief Scientific Officer, Chris Proctor, is in San Diego at the Spring National Meeting of the American Chemical Society. Chris presented at the 2015 Autumn National Meeting in a session on Scientific Integrity. In San Diego, Chris continues his work as a committee member of the Corporate Associates Division.
As part of our open and transparent approach, we have designed an interactive visitor exhibit to showcase our science. Our exhibit room, R&D Live, puts you in direct conversation with our scientists as they explain the concept of their work.